Lijun Gao

Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non‐alcoholic fatty liver disease: A randomized trial

Dalong Zhu, Y. Bi, S. Shen, 2018, Journal of diabetes investigation.

Liraglutide Attenuates Nonalcoholic Fatty Liver Disease by Modulating Gut Microbiota in Rats Administered a High-Fat Diet

Dalong Zhu, Y. Bi, W. Feng, 2020, BioMed research international.

Effects of exenatide versus insulin glargine on body composition in overweight and obese T2DM patients: a randomized controlled trial

Dalong Zhu, Y. Bi, S. Shen, 2018, Nutrition & Metabolism.

Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial

Dalong Zhu, Xiao-lu Xiong, Y. Bi, 2018, Diabetes Therapy.

Comparison of Beinaglutide Versus Metformin for Weight Loss in Overweight and Obese Non-diabetic Patients

Lu Zhang, Dalong Zhu, Y. Bi, 2021, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non‐alcoholic fatty liver disease: A randomized trial

Dalong Zhu, Y. Bi, S. Shen, 2018, Journal of diabetes investigation.